{"entity":{"type":"insider","cik":"0001328146","url":"/insider/0001328146","json_url":"/insider/0001328146.json","name":"Kiener Peter A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2006-02-09","last":"2023-03-27","span_basis":"filed_date"},"name_variants":[{"name":"Kiener Peter A","source":"filing","n_filings":4,"first_seen":"2006-02-09","last_seen":"2023-03-27"}],"transactions":[{"id":7968619,"accession":"0001209191-23-021201","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-021201","line_url":"/filing/0001209191-23-021201#line-2","is_derivative":false,"issuer_cik":"0001328146","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001328146","owner_cik":"0001328146","owner_name":"Kiener Peter A","owner_display_name":"Kiener Peter A","owner_url":"/insider/0001328146","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9325.0,"shares_display":"9,325","price_per_share":3.28,"price_display":"3.28","price_state":"stated","total_value":30586.0,"total_display":"30,586.00","total_whole":"30,586","shares_owned_after":357.0,"shares_owned_after_display":"357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-27","scope":"insider"},{"id":5277116,"accession":"0000899243-21-045070","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-045070","line_url":"/filing/0000899243-21-045070#line-4","is_derivative":false,"issuer_cik":"0001328146","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001328146","owner_cik":"0001328146","owner_name":"Kiener Peter A","owner_display_name":"Kiener Peter A","owner_url":"/insider/0001328146","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1361.0,"shares_display":"1,361","price_per_share":18.02,"price_display":"18.02","price_state":"stated","total_value":24525.22,"total_display":"24,525.22","total_whole":"24,525","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-17","scope":"insider"},{"id":5277112,"accession":"0000899243-21-045070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-045070","line_url":"/filing/0000899243-21-045070#line-2","is_derivative":false,"issuer_cik":"0001328146","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001328146","owner_cik":"0001328146","owner_name":"Kiener Peter A","owner_display_name":"Kiener Peter A","owner_url":"/insider/0001328146","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18815.0,"shares_display":"18,815","price_per_share":17.92,"price_display":"17.92","price_state":"stated","total_value":337164.8,"total_display":"337,164.80","total_whole":"337,165","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider"},{"id":4789846,"accession":"0001171843-17-007595","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001171843-17-007595","line_url":"/filing/0001171843-17-007595#line-2","is_derivative":false,"issuer_cik":"0001328146","issuer_name":"Sucampo Pharmaceuticals, Inc.","issuer_ticker":"SCMP","issuer_name_source":null,"issuer_url":"/issuer/0001328146","owner_cik":"0001328146","owner_name":"Kiener Peter A","owner_display_name":"Kiener Peter A","owner_url":"/insider/0001328146","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock, Class A","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":825000.0,"total_display":"825,000.00","total_whole":"825,000","shares_owned_after":2023.0,"shares_owned_after_display":"2,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-07","filed_date":"2017-12-11","scope":"insider"},{"id":3756724,"accession":"0000873591-06-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000873591-06-000006","line_url":"/filing/0000873591-06-000006#line-2","is_derivative":false,"issuer_cik":"0000873591","issuer_name":"MEDIMMUNE INC /DE","issuer_ticker":"MEDI","issuer_name_source":null,"issuer_url":"/issuer/0000873591","owner_cik":"0001328146","owner_name":"Kiener Peter A","owner_display_name":"Kiener Peter A","owner_url":"/insider/0001328146","role":"Officer (SVP, Research)","role_mark":"O","role_mark_label":"Officer (SVP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":33.4129,"price_display":"33.41","price_state":"stated","total_value":400954.8,"total_display":"400,954.80","total_whole":"400,955","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-02-08","filed_date":"2006-02-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645460","name":"Cue Biopharma, Inc.","url":"/issuer/0001645460","role":"Director","n_filings":2,"first_seen":"2021-11-17","last_seen":"2023-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001365216","name":"Sucampo Pharmaceuticals, Inc.","url":"/issuer/0001365216","role":"Officer (Chief Science Officer)","n_filings":1,"first_seen":"2017-12-11","last_seen":"2017-12-11"},{"type":"issuer","type_label":"ISSUER","cik":"0000873591","name":"MEDIMMUNE INC /DE","url":"/issuer/0000873591","role":"Officer (SVP, Research)","n_filings":1,"first_seen":"2006-02-09","last_seen":"2006-02-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001328146","retrieved_at":"2026-08-24T11:26:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}